ESC Professional Premium Access

When to consider AF ablation: outcome and survival in specific cohorts – discussion.

Congress Session

4 more presentations in this session

Does first line atrial fibrillation ablation improve survival in HFrEF?

Speaker: Associate Professor J. Piccini (Durham, US)

Thumbnail

Does first line atrial fibrillation ablation improve survival in HFpEF?

Speaker: Professor G. Hindricks (Leipzig, DE)

Thumbnail

Does first line AF ablation improve outcome in hypertrophic cardiomyopathy patients?

Speaker: Doctor A. Creta (London, GB)

Thumbnail

Does first line AF ablation improve outcome in asymptomatic patients?

Speaker: Professor K. Chun (Frankfurt am Main, DE)

Thumbnail

Access the full session

When to consider AF ablation: outcome and survival in specific cohorts

Speakers: Associate Professor J. Piccini, Professor G. Hindricks, Doctor A. Creta, Professor K. Chun
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk